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Introduction
Secretory and membrane proteins are synthesized in the ER and 
undergo appropriate posttranslational modifications and fold-
ing before making their way through the anterograde secretory 
pathway, including the Golgi complex, to their final destination 
(Rothman, 1994). While in transit, they undergo further modi-
fications, e.g., trimming or addition of the glycosyl residues 
on an N-glycosylated protein. The posttranslational modifica-
tions bestowed upon any protein is unique to that individual 
protein and is directed in part by discrete signals that reside in 
the protein itself, and the alterations are determined by modi-
fying proteins that are segregated in distinct organelles along 
the secretory pathway (Barlowe and Miller, 2013). In general, 
the folding and early posttranslational modifications rendered 
in the ER ensure the overall functional fitness of many proteins; 
however, the stability, specificity, and proper localization of a 
significant fraction of transported proteins is influenced greatly 
by their fate in the post-ER compartments. An essential task of 
the cell is to safeguard that each of these proteins is delivered 
to the correct subcellular location. An important interaction of 
a newly synthesized secretory/membrane protein is with the 
coat protein II (COPII) complex that ensures proper packaging 
into ER-derived membrane vesicles and delivery to the Golgi 
complex. COPII protein complex consists of five core pro-
teins: Sar1, Sec23, Sec24, Sec13, and Sec31 (Fromme et al., 
2008; Zanetti et al., 2012). Activated Sar1 recruits Sec23/Sec24 
The coat protein II (COPII)–coated vesicular system transports newly synthesized secretory and mem-brane proteins from the endoplasmic reticulum (ER) 
to the Golgi complex. Recruitment of cargo into COPII 
vesicles requires an interaction of COPII proteins either 
with the cargo molecules directly or with cargo receptors 
for anterograde trafficking. We show that cytosolic phos-
phatidic acid phospholipase A1 (PAPLA1) interacts 
with COPII protein family members and is required for 
the transport of Rh1 (rhodopsin 1), an N-glycosylated 
G protein–coupled receptor (GPCR), from the ER to the 
Golgi complex. In papla1 mutants, in the absence of 
transport to the Golgi, Rh1 is aberrantly glycosylated and 
is mislocalized. These defects lead to decreased levels of 
the protein and decreased sensitivity of the photorecep-
tors to light. Several GPCRs, including other rhodopsins 
and Bride of sevenless, are similarly affected. Our find-
ings show that a cytosolic protein is necessary for transit 
of selective transmembrane receptor cargo by the COPII 
coat for anterograde trafficking.
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Golgi complex. Steady-state and pulse–chase experiments, 
in vivo, show that a significant fraction of the newly synthesized 
Rh1 is ectopically localized and unstable in the mutant. The de-
fective transport of Rh1 contributes to the progressive decline in 
steady-state levels of Rh1 in the flies, leading to decreased abil-
ity of the mutants to transduce light signal. In addition, the mu-
tant flies show other phenotypes, such as male sterility, increased 
starvation sensitivity, and locomotor defects. Our experiments 
support the conclusions that the PAPLA1 protein is required for 
the physiological transit of a family of N-linked glycosylated 
proteins from the ER to the Golgi complex.
Results
CG8552 is a PAPLA1
Sequence analysis indicated that PAPLA1 gene CG8552 is the 
only homologue in Drosophila. Multiple sequence alignments 
and phylogenetic analysis showed that DDHD1 and CG8552 
share a common ancestor, and DDHD2 and Sec23IP (p125) 
evolved from an even earlier ancestor (Fig. 1 A). A 31-kb ge-
nomic fragment modified to carry a V5 epitope at the N terminus 
of the PAPLA1 (V5-N-PAPLA1) protein was fully functional in 
Drosophila and rescued all the phenotype of a null mutant (see 
later in this paper and Fig. S3, A and B). These flies were used 
in immunofluorescence experiments for subcellular localization 
of the endogenous PAPLA1 protein. To determine the subcel-
lular distribution of the protein accurately, we were able to use 
a demonstration superresolution structured illumination micro-
scope (SR-SIM; ELYRA S1 [Carl Zeiss]). The protein showed 
strong colocalization with the Sec23 protein in a number of tis-
sues, including oocyte and male accessory gland (Fig. 1, B and C). 
Sec23 and PAPLA1 colocalization was also detectable by 
confocal microscopy. Fig. S1 A is a confocal image of a section 
from the superficial layer of the accessory gland where the im-
munostained structures are slightly larger (71 ± 12% of clearly 
visible Sec23 signals overlapped with PAPLA1, and 75 ± 13% 
of PAPLA1 signals overlapped with Sec23). We were able to 
demonstrate the presence of Sec23 in immunoprecipitates of the 
V5-tagged PAPLA1 from Drosophila head extracts (Fig. 1 D). 
Sec23 protein is enriched at the ER exit sites, a cytoplasmic 
zone between the transitional ER and the Golgi complex, 
where it is associated with a population of vesicles and tubules 
(Kondylis et al., 2007). PAPLA1’s localization is also distinct 
from Lava lamp, a peripheral Golgi protein (Fig. S1 B; Sisson 
et al., 2000). A stable S2 cell line expressing a C-terminally V5-
tagged PAPLA1 was established, and Flag-tagged Drosophila 
Sec23 and Sec31 were individually expressed in this cell line. 
Immunoprecipitation experiments of the V5-tagged PAPLA1 
showed direct interaction between PAPLA1 and Sec23 and also 
between PAPLA1 and Sec31 (Fig. S1 C). These results are rem-
iniscent of the interaction of mammalian p125 proteins with the 
COPII complex (Tani et al., 1999; Ong et al., 2010). Thus, the 
subcellular localization of PAPLA1 and its interactions raise the 
possibility that PAPLA1 could play a role in trafficking of pro-
teins between ER and the Golgi complex. To ascertain whether 
the protein displayed enzymatic activity, we generated trans-
genic flies expressing PAPLA1 using the upstream activating 
dimers to the point of coat formation on the ER membrane to 
form the so-called inner coat. A heterotetramer of Sec13/Sec31 
is subsequently organized around this inner coat to form an outer 
coat. These polymerize into a latticelike structure that drives 
membrane curvature. The stochastic sampling model predicts 
that the cargo enters the vesicles by bulk flow, thus allowing for 
sampling of the contents of the lumen and membrane by chance. 
This could explain the transport of abundant cargo molecules 
but is insufficient to explain cargoes that get enriched in the vesi-
cles beyond their existing concentration (Pfeffer and Rothman, 
1987; Pelham, 1989; Balch et al., 1994; Klumperman, 2000; 
Barlowe and Miller, 2013). The selective cargo capture scheme 
involves direct interaction of the cargo with the coat proteins via 
the cargo ER exit signals or, in the case of some soluble secre-
tory proteins, could entail the utilization of cargo receptors that 
would recognize the cargo and link them to the coat proteins. 
Proteins such as Erv29p in yeast and Tango 1 in mammals cou-
ple secretory cargo molecules to the COPII coat (Belden and 
Barlowe, 2001; Saito et al., 2009).
Enzymatic activity of phospholipase D and enrichment of 
phosphatidic acid at the ER exit sites have implied a role for 
lipids in COPII vesicle budding (Pathre et al., 2003). Phospha-
tidic acid phospholipase A1 (PAPLA1) enzymes hydrolyze the 
ester bond at the Sn-1 position. The mammalian intracellular 
PAPLA1 family is comprised of three members. DDHD1, the 
canonical cytosolic PAPLA1, was purified from bovine testis 
based on its ability to deacylate phosphatidic acid at Sn-1 posi-
tion to generate fatty acid and Sn-2 lysophosphatidic acid (Higgs 
and Glomset, 1996). DDHD2 or KIAA0725p is present in the 
Golgi/ER–Golgi intermediate, and its knockdown in tissue cul-
ture cells can retard the transport of VSVG from the Golgi ap-
paratus (Sato et al., 2010). Sec23-interacting protein (Sec23IP; 
or p125) is a homologue of PAPLA1, and its interaction with 
Sec23 and Sec31 suggested a potential role for this protein in 
the assembly of COPII proteins and thus a possible role in pro-
tein transport (Shimoi et al., 2005; Ong et al., 2010). However, 
a function for this protein or its homologues in transport of spe-
cific cargo has not been demonstrated. Mutations in DDHD1 
and DDHD2 are associated with hereditary spastic paraplegia 
in humans (Schuurs-Hoeijmakers et al., 2012; Tesson et al., 
2012; Fink, 2013; Gonzalez et al., 2013). The target proteins, if 
any, compromised in these mutants have yet to be identified. 
A mouse null mutant for the p125 protein was recently reported, 
and the mutant male mice are subfertile (Arimitsu et al., 2011). 
Again, a specific function for this protein in protein transport 
was not described in the study.
In this study, we delineate a transport function for the 
PAPLA1 homologue in Drosophila melanogaster. Our study 
shows that PAPLA1 is an authentic PAPLA1 and a protein that 
interacts with members of the COPII carriers. We have gener-
ated a null mutant for this gene and show that the mutant affects 
several N-linked glycosylated G protein–coupled receptors 
(GPCRs), including Rh1 (rhodopsin 1) and Boss (Bride of sev-
enless). Genetic epistasis experiments and cell biological analy-
sis show that the steady-state levels of Rh1 are compromised 
with an altered glycosylation pattern. We show that these changes 
are caused by defects in transport between the ER and the 
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Figure 1. Homology, localization, interaction, and enzymatic activity of PAPLA1. (A) Cladogram of the DDHD1, DDHD2, Sec23IP (human), and CG8552. 
The numbers indicate the tree distance. (B and C) SR-SIM of the Drosophila female oocyte (B) and male accessory gland (C). The Golgi was probed with 
a monoclonal antibody raised against a 120-kD Golgi-integral membrane protein. (D) The Sec23 protein is detectable in immunoprecipitates of PAPLA1 
from Drosophila heads. Contactin and CERT serve as negative controls. (E) PAPLA1 activity measured in extracts from control and PAPLA1-overexpressing 
Drosophila head extracts. The error bars indicate standard error of the means. IP, immunoprecipitation; LPA, lysophosphatidic acid.
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between three- and fivefold in the mutant and were worse in the 
older flies (Fig. S2, A and B). Rh1 is a prototypic member of the 
GPCR family. It is expressed in R1–R6 photoreceptor cells and 
is the most abundant rhodopsin in flies. We inquired whether 
other rhodopsins were similarly affected in papla1 mutants. 
Rh3 and Rh4 are minor rhodopsins expressed in nonoverlapping 
sets of R7 photoreceptor cells. Rh5 and Rh6 are expressed in 
nonoverlapping sets of R8 cells. The endogenous levels of these 
proteins are very low, and available monoclonal antibodies did 
not detect these proteins in Western blots. Therefore, we used 
transgenic flies that express Rh3 and Rh5 proteins in R1–R6 
cells under the Rh1 promoter. The use of the Rh1 promoter ex-
pands the expression of Rh3 and Rh5 to R1–R6 cells and renders 
them visible by immunoblot analysis. We probed for ectopically 
expressed Rh3 and Rh5 by Western blot analysis in both the 
wild-type control and the papla1 mutant fly background. Like 
with Rh1, the levels of Rh3 and Rh5 were greatly reduced in 
the mutant compared with the control flies (Fig. 2, D and E). 
Thus, the loss of PAPLA1 affects the steady-state levels of sev-
eral rhodopsins in Drosophila. Finally, we explored whether a 
GPCR other than rhodopsin was affected in the papla1 mutant. 
Boss is a GPCR originally identified as a ligand for the recep-
tor tyrosine kinase sevenless in determining the fate of R7 cells 
in developing ommatidia of Drosophila (Hart et al., 1990). 
A recent study showed that in adult flies, Boss also responds 
to extracellular glucose and regulates sugar and lipid metabolism 
(Kohyama-Koganeya et al., 2008). Our analysis indicates that 
levels of the Boss protein were also decreased in the papla1 
mutant (Fig. 2 F). The decline worsens with aging, and older 
flies have almost a fourfold decrease in the steady-state lev-
els of the protein compared with the controls (Fig. S2 C). 
We checked whether PAPLA1 would be required for the transport 
of other N-glycosylated proteins. Contactin is a glycosylphos-
phatidylinositol-anchored cell adhesion molecule that contains 
immunoglobulin domains linked to fibronectin type III repeats 
and is N-glycosylated (Faivre-Sarrailh et al., 2004). This pro-
tein is predominantly expressed in the neurons and is implicated 
in control of axonal growth. Western blot analysis showed that 
neither the protein levels nor the apparent molecular mass of 
contactin was affected in the papal1 mutant. Thus, contactin is not 
compromised in the papla1 mutant (Fig. S2 F). Neuroglian is 
an integral membrane protein and a cell adhesion molecule ex-
pressed in the central nervous system and is also N-glycosylated 
(Bieber et al., 1989). We were unable to observe discernable 
changes in the levels or molecular mass of neuroglian from the 
papla1 mutant (Fig. S2 G). Thus, the deficiency of PAPLA1 
protein selectively affects the steady-state levels of a subset of 
GPCR family members in Drosophila.
As mentioned previously in this paper, Rh1 is not only 
decreased in the mutant flies but is also of slightly higher 
molecular mass (by 2–3 kD; Fig. 2 C). Indeed, changes in 
the apparent molecular mass were observed in other proteins 
too. Unlike Rh1, the apparent molecular mass of the Boss 
protein in the mutant was slightly lower than in the wild-
type control (Fig. 2 F and Fig. S2, C–E). The difference in 
the steady-state levels and apparent molecular mass of the 
proteins in the wild-type control and the mutant flies indicates 
sequence (UAS)–GAL4 system in the eye. Fly extracts contain-
ing the overexpressed protein showed a significant increase in 
the PAPLA1 activity compared with the control (Fig. 1 E). Inci-
dentally, the mammalian p125 that colocalizes with Sec23 lacks 
the enzymatic activity (Nakajima et al., 2002). On the other 
hand, both DDHD1 and DDHD2 demonstrate phospholipase 
A1 activity (Higgs and Glomset, 1996; Nakajima et al., 2002). 
Thus, the lone Drosophila PAPLA1 protein could encode func-
tions that overlap with all three mammalian family members.
GPCRs are compromised in a  
PAPLA1-null mutant
The CG8552 gene is localized to the left arm of the second 
chromosome and is encoded by a 25-kb (25,328 bp) gene with 
seven exons. It translates into a protein containing 2,016 amino 
acids with an N-terminal proline-rich region, a WWE domain, 
and a C-terminal DDHD domain (Fig. 2 A). The protein is con-
siderably longer than the three mammalian homologues. Much 
of the homology with the mammalian proteins is confined to the 
C-terminal 700 amino acids. The N-terminal proline-rich region 
shows no significant homology with known mammalian pro-
teins. To delineate a role for PAPLA1 in vivo, we generated a 
null deletion mutant using ends-out homologous recombination 
(Gong and Golic, 2003). The design of homology arms used 
for creation of the targeting vector and the nature of deletion is 
summarized in Fig. 2 B. The two exons retained in the mutant 
encode a protein of only 81 amino acids, and thus, the mutant 
flies are functionally null for all practical purposes. Drosophila 
phototransduction has served as a good model for the study of 
protein trafficking as well as posttranslational modification of 
proteins and membrane turnover experiments. Therefore, we 
analyzed Drosophila head extracts to probe for proteins of pho-
totransduction in the hope of unraveling clues to the transport 
function for PAPLA1, if any. Previous studies in mutant mouse 
and tissue culture cells had failed to identify specific targets 
that were affected by DDHD1, DDHD2, or the p125 protein 
(Arimitsu et al., 2011; Schuurs-Hoeijmakers et al., 2012; Tesson 
et al., 2012; Gonzalez et al., 2013). We found a consistent and 
significant decrease in the levels of rhodopsin (Rh1) in Western 
blots from papla1 mutant head extracts compared with wild-type 
controls, and the residual Rh1 also exhibited a slightly higher 
apparent molecular mass (Fig. 2 C). Other phototransduction 
components, such as NorpA (No receptor potential A), transient 
receptor potential (Trp), and NinaC, were not significantly af-
fected in the mutants (Fig. S1 D). The decrease in Rh1 levels 
and the altered molecular mass were observed when the flies 
were either exposed to light (in a day/night pattern) or raised 
in total darkness (Fig. S2, A and B). These results indicate that 
changes in the apparent molecular mass and steady-state levels 
of Rh1 in papla1 mutants were not likely a result of the activa-
tion and involvement of the phototransduction cascade (such 
as increased Rh1 turnover after endocytosis upon light-induced 
stimulation) but rather intrinsic to the properties of Rh1 ren-
dered during either synthesis, posttranslational modification, or 
trafficking of the protein. The decrease in Rh1 was not caused 
by photoreceptor degeneration (Fig. 3 C). Depending on the 
age of the fly, the steady-state levels of Rh1 were decreased 
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Fig. 5 E). Also, in S2 cells, transiently expressed PAPLA1 co-
immunoprecipitated with the Boss protein, indicating a physical 
interaction between PAPLA1 and the two GPCRs (Fig. 5 F). 
Although these experiments indicate a physical interaction, we do 
that the deficiency of PAPLA1 compromises the fate of sev-
eral GPCRs.
In microsomal preparations, a small fraction of the Rh1 
was found to immunoprecipitate with PAPLA1 in vivo (see 
Figure 2. papla1-null mutant affects the integrity of several of GPCRs. (A) The genomic organization (top), the proteins domains (bottom), and the protein 
sequence of PAPLA1. (B) The green box in the top drawing represents the homology arms used for generation of the papla1-null allele, and the middle 
shows the exons retained in the null mutant. The bottom shows the encoded protein in the papla1 mutants. (C–F) Western blots of head extracts from the 
control and papla1 mutant flies probed with anti-Rh1 (C), Rh3 (D), Rh5 (E), and Boss (F).
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and transport of Rh1. We found that the steady-state levels of 
NinaA were always higher in the mutant compared with wild-
type controls, perhaps indicative of incipient ER stress in 
papla1 mutants (Fig. 3, Fig. S1 D, and Fig. S3 C). We decided 
to examine the epistatic relation between ninaA and papla1 
in the hope it would enable us to genetically dissect the point 
of action of PAPLA1 protein during the synthesis and trans-
port of Rh1. We used two ninaA mutant alleles for genetic 
epistasis experiments.
In ninaA269 (ninaA3) mutants, Rh1 levels are low, and 
most of the residual Rh1 appears as a nearly 40-kD protein that 
accumulates in the ER (Fig. 3 A; Colley et al., 1991; Webel 
et al., 2000). This mutant has an H227L mutation in the NinaA 
protein, which renders it extremely unstable, the flies show very 
not know whether this is a direct physical interaction or if they 
are part of a larger complex. Because Rh1 is a well-studied protein 
and phototransduction cascade has been intensively investigated, 
we decided to focus on this protein to probe deeper into the de-
fects observed in the N-linked GPCR family in papla1 mutants.
PAPLA1 is required for the ER to Golgi 
transit of Rh1
The Rh1 protein is synthesized in rough ER and is glycosylated 
initially to a 40-kD high molecular mass form that then under-
goes progressive deglycosylation along the secretory pathway, 
including the Golgi complex. NinaA (Neither inactivation nor 
after potential) protein is a peptidyl-prolyl cis–trans isomerase 
that initiates function as a chaperone in the ER during the folding 
Figure 3. PAPLA1 acts downstream of the Rh1 chaperone NinaA and upstream of the Golgi-resident protein dMPPE. (A) Western analysis of single head 
extracts from control, papla1, ninaA269, ninaA1, papla1-ninaA269 double mutant, and papla1-ninaA1 double mutant flies. (B) The same blot was probed 
with the NinaA antibody. NinaA protein levels are increased in all of the papla1 mutant backgrounds that have a functional NinaA protein, including 
the ninaA1-papla1 double mutants. (C) Electron microscopy from the control, papla1, ninaA269, and ninaA269-papla1 double mutant backgrounds. The 
boxed regions shown in ninaA269 and ninaA269-papla1 double mutants have been enlarged. (D) Increased expression of NinaA in papal1 mutants does 
not result in increased steady-state levels of Rh1. Single fly head extracts of newly eclosed flies of the appropriate genotype were probed for Rh1, tubulin, 
and NinaA. The same blot was probed for all three antibodies. (E) Western blots of protein extracts from control and dmppe mutant flies. The same blot 
was probed for all three antibodies.
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mutant. Because the Rh1 in the papla1 mutant is also of a simi-
lar molecular mass as in the dmppe mutant, we performed ge-
netic epistasis experiments to evaluate whether PAPLA1 acts 
upstream of dMPPE, the Golgi-resident enzyme. We generated 
a papla1-dmppe double mutant and tested the Rh1 levels by 
Western blot analysis. As seen in Fig. 3 E, the apparent mo-
lecular mass of Rh1 is similar in both the dmppe and papla1 
mutant, and they are both slightly larger than wild-type Rh1. 
Although the amounts of Rh1 in wild-type control and dmppe 
are comparable, the papla1-dmppe double mutant retains the 
phenotype of papla1 because the Rh1 levels are reduced to that 
observed in papal1 mutant, indicating that most likely PAPLA1 
acts upstream of dMPPE. Furthermore, the degree of reduced 
SDS-PAGE mobility observed in the dmppe single and dmppe-
papla1 double mutant is similar to the shift observed in the 
papla1 single mutant, suggesting that both mutations may im-
pact the same glycan processing step.
The aforementioned genetic experiments indicate that 
PAPLA1 acts downstream of NinaA. Our observations also sug-
gest that it acts upstream of dMPPE, in the maturation of Rh1 
in Drosophila photoreceptors. Combined with the findings from 
immunolocalization and coimmunoprecipitation experiments 
described previously in this paper, we believe that PAPLA1 acts 
along the ER–Golgi axis either at the ER exit sites or at the 
ER–Golgi contact point and is required for the anterograde traf-
ficking of Rh1 from the ER to the Golgi complex.
PAPLA1 is required for Golgi processing  
of the GPCRs
In the wild-type control flies, the ER glycosylated Rh1 is either 
extensively trimmed or completely divested of sugar residues in 
the Golgi complex before being delivered as a mature protein 
(with an apparent molecular mass of 32 kD) to the rhabdomere 
(Huber et al., 1990; Katanosaka et al., 1998). The molecular 
mass of Rh1 in the papla1 mutant is similar to those reported 
for dmppe and -Man-II mutants, in which the deglycosylation 
of Rh1 in the Golgi complex is compromised (Walther and 
Pichaud, 2006). Rh1 undergoes core N-linked glycosylation in 
the ER, and these glycosyl moieties undergo processing as the 
protein transits from the ER through the Golgi complex to the 
rhabdomere (Katanosaka et al., 1998; Webel et al., 2000). 
To evaluate whether the observed difference in Rh1 was a result 
of a lack of processing of glycosyl residues in the Golgi com-
plex, we subjected Rh1 from both control and mutant extracts 
to peptide N-glycosidase F (PNGase F) treatment. PNGase F 
cleaves between the innermost GlcNAc and asparagine residues 
of N-linked glycoproteins (Maley et al., 1989). If the differ-
ence in apparent molecular mass of the Rh1 in mutants was 
caused by defects in glycosylation, treatment with PNGase F 
should yield Rh1 proteins of similar molecular masses in both 
the control and the mutants. Indeed, PNGase F treatment of 
wild-type and mutant extracts results in Rh1s that are indistin-
guishable by molecular mass (Fig. 4 A). These results indicate 
that the observed difference in the molecular mass was caused 
by altered glycosylation patterns of Rh1 in the two genetic back-
grounds. We also wanted to test whether the other GPCR, Boss, 
showed a similar glycosylation defect. Boss is also an N-linked 
little mature Rh1 in the rhabdomere, and much of the Rh1 is in 
the immature form in the ER (Colley et al., 1991; Webel et al., 
2000). The mutant flies also show proliferation of the ER (Fig. 3 C; 
Colley et al., 1991). The second mutant ninaA1 encodes a trun-
cated NinaA (W208*) that is partially active at room tempera-
ture and is a temperature-sensitive allele (Colley et al., 1991). 
In these flies, Rh1 is of normal molecular mass, but its levels are 
reduced at 25°C (Fig. 3 A).
In ninaA269-papla1 double mutants, the Rh1 levels are 
low, and the residual Rh1 is 40 kD, similar to the phenotype 
of ninaA269 allele, thus demonstrating that NinaA acts upstream 
of PAPLA1 (Fig. 3, A and B). If this is true, we predict that in a 
double mutant of papla1 and the hypomorphic ninaA1, the small 
amount of mature Rh1 observed in the ninaA1 hypomorph will 
now migrate as in a papla1-null fly. Indeed, in the ninaA1-papla1 
double mutant in which NinaA is still partially active, the appar-
ent molecular mass of the mature Rh1 shifts to that observed in 
papla1. As in papla1 mutants, we also observe up-regulation of 
the truncated NinaA protein in the ninaA1-papla1 double mu-
tant (Fig. 3 B). It is worth noting that, in the ninaA269-papla1 
double mutant, we saw severe dilation of the ER, indicating that 
the ER stress observed in ninaA269 mutants (manifested as pro-
liferation of ER) is exacerbated when PAPLA1 is lost in these 
flies (Fig. 3 C). The genetic epistasis data, the colocalization 
of PAPLA1 with Sec23 protein, and the ER dilation observed 
in the ninaA269-papla1 double mutants together suggest that 
PAPLA1 acts immediately downstream of the site of action of 
NinaA in the immediate proximity of the ER, during the trans-
port of Rh1. Because NinaA protein levels were increased in the 
papla1 mutant and NinaA is a known chaperone for Rh1 protein, 
we wondered whether the increased levels of NinaA were used 
for stabilizing the immature Rh1 found in the papla1 mutant or 
whether it was an indicator of an underlying ER stress. If the in-
creased NinaA is stabilizing the residual Rh1 in the papla1 mu-
tant, overexpression of the protein should stabilize and increase 
the Rh1 levels. To test this, we generated NinaA transgenic flies 
and specifically overexpressed them in the photoreceptor cells 
using the long glass multimer reporter–Gal4 driver lines (Wernet 
et al., 2003). Increased expression of NinaA, however, did not 
increase the levels of Rh1 in the papla1 mutant. These results 
support the notion that incipient ER stress in papla1 may be 
responsible for the up-regulation of NinaA protein levels, but 
increasing the NinaA levels does not result in increased steady-
state levels of Rh1 in papla1 mutants (Fig. 3 D).
Because PAPLA1 colocalizes with components of COPII 
coat proteins, which are enriched at the ER exit sites, we pre-
dict that the papla1 phenotype will dominate over that of a 
mutant for a Golgi-resident protein involved in Rh1 transport. 
dMPPE (CG8889) is a Golgi-resident metallophosphoesterase 
that dephosphorylates -Man-II (-Mannosidase II) and acti-
vates it (Cao et al., 2011). In CG8889e02905 (dmppe), a mutant 
of CG8889, -Man-II, remains phosphorylated and is inactive. 
Because -Man-II is inactive in the Golgi, the Rh1 that tran-
sits through the Golgi in this mutant is not deglycosylated by 
-Man-II. The additional sugar residues on Rh1 in the dmppe 
mutant increase the molecular mass of the protein slightly, but 
the steady-state level of Rh1 is not significantly altered in the 
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mutant would be conservatively expected to be less, based on 
silver staining. After SDS-PAGE and silver staining of the im-
munoprecipitations, Rh1 bands were excised away from the rest 
of the gel, and the resulting gel pieces were subject to in-gel 
tryptic digestion. N-linked glycans were released from the gly-
copeptides by PNGase F digestion and further analyzed by MS 
as their permethylated derivatives. Despite the lower amount of 
Rh1 obtained from papla1 mutant heads, the abundance of total 
N-linked glycans was substantially greater (Fig. 4 C). Among 
the major glycans detected by our analysis, the Man5GlcNAc2 
structure (M5N2) dominated the profile in both wild types and 
the papla1 mutant. The M5N2 glycan is the substrate for the 
Golgi -Man-II enzyme that is inactivated in the dmppe mutant 
(Fig. 3 E). Therefore, the increase in M5N2 in the papla1 mu-
tant is consistent with decreased Golgi processing of Rh1. The 
oligosaccharide chain in mature Rh1 from control photorecep-
tors would be extensively trimmed or completely removed, and 
hence, there are fewer glycosylated chains in the eluate (Huber 
et al., 1990; Katanosaka et al., 1998). Thus, any glycosylated 
Rh1 evaluated in the control would be the small amounts of im-
mature Rh1. Indeed, all of the major N-linked glycans detected 
on wild-type Rh1 were substantially increased in abundance on 
Rh1 from papla1, which is consistent with hyperglycosylation 
glycoprotein, and a monoclonal antibody was able to detect a 
small but consistent difference in the molecular mass of the pro-
tein in the wild-type and mutant background (Fig. S2, C–E). 
However, in this instance, the observed molecular mass of the 
mutant protein is lower than the wild type. Because Golgi pro-
cessing can either remove or add additional sugars, it is likely 
that in the case of Boss, the modifications that occur in the Golgi 
in the wild-type flies result in increased oligosaccharide chain 
lengths. Like with Rh1 proteins, PNGase F treatment results in 
Boss proteins of similar molecular masses from the two back-
grounds (Fig. S2 H).
To evaluate the extent of glycosylation of Rh1 expressed 
in wild type and the papla1 mutant, we performed N-linked gly-
can analysis by mass spectrometry (MS). Rh1 was immunopre-
cipitated from 100 wild-type and 100 mutant heads using the 
4C5 antibody (Fig. 4 B). After silver stain of the immunoprecip-
itated material, the Rh1 levels were quantified by densitometric 
scanning and found to be more than eightfold less in the mutant 
compared with wild type. Therefore, to obtain sufficient mate-
rial from the papla1 mutant, Rh1 was immunoprecipitated from 
500 total mutant heads for comparison with Rh1 precipitated 
from 100 wild-type heads. Thus, despite precipitating from five-
fold more mutant heads, the total Rh1 harvested from the papla1 
Figure 4. The increased apparent molecular 
mass of Rh1 in the papal1 mutant is caused 
by defective deglycosylation. (A) Western 
blot analysis of Rh1 molecular masses be-
fore and after treatment with PNGase F in 
control w1118 and papla1 mutants. (B) Immuno-
precipitates of Rh1 from control w1118 and 
papla1 mutants. The decreased amounts and 
higher molecular masses of the immunopre-
cipitated proteins can be appreciated in the 
silver-stained gels. Quantification by densi-
tometry indicates that the papla1 mutant has 
greater than eightfold less Rh1 than wild type. 
(C) Mass spectrometric analysis of N-glycans 
linked to Rh1 in wild-type and papla1 mutant 
heads. N-linked glycans were released from 
Rh1, which was immunoprecipitated from 100 
wild-type or 500 papla1 head extracts. (blue 
squares, N-acetylglucosamine; green circles, 
mannose), and the labels along the x axis 
refer to the composition of the glycan based 
on number of mannose residues (M) and 
number of N-acetylglucosamine residues (N). 
The MS samples were run in triplicates with 
identical results. The biological experiment 
was completed once with pooled Rh1 as de-
scribed in the Results section describing the 
glycosylation patterns observed in mutant and 
wild-type Rh1.
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in wild-type controls, we performed colocalization experiments 
with papla1 mutants at 10 h to observe the subcellular location 
of Rh1. In the mutant, the ectopic Rh1 predominantly colocal-
ized with calnexin, an ER-resident protein. No significant co-
localization was observed with Rab7 (Fig. S5, A and B). The 
pattern of Rh1 staining was similar to that observed in ninaA269 
(Fig. S5 C). Rh1 has been shown to colocalize with Golgi mark-
ers during the early stages of rhodopsin biosynthesis in develop-
ing pupae (Cao et al., 2011). We used these flies to colocalize 
the Rh1 and the Golgi complex in the wild-type and mutant 
backgrounds. For these experiments, we fixed flies 4 h after 1 h 
of hs induction and performed immunolocalization experiments 
for Rh1 and a Golgi marker. Although we saw partial colocal-
ization of Rh1 with the Golgi marker in wild-type flies, we did 
not see colocalization of the Rh1 and the Golgi marker in the 
mutant (Fig. 5 C).
We recombined V5-N-PAPLA1 rescued flies to hs-Rh1-
1D4 lines and examined whether we could colocalize PAPLA1 
and Rh1. For this experiment, we induced the production of 
Rh1 with hs at 37°C for 2 h and performed the whole-mount im-
munostaining of the eye with antibodies against Rho-1D4 and 
V5, 2 h after the hs. Under these conditions, dispersed between 
the reticular staining of Rh1, we see a faint but distinct overlap 
of signals from PAPLA1 and Rh1, and together with the results 
from immunoprecipitation experiments described previously in 
this paper, these data suggest that the two proteins could interact 
(Fig. 5 D–F).
The active site of PAPLA1 is not 
necessary for Rh1 maturation
Transgenic overexpression of PAPLA1 results in increased en-
zymatic activity. Also, a 31-kb genomic construct containing 
either untagged or N-terminal V5 epitope–tagged PAPLA1 was 
able to rescue all the phenotypic defects observed in papla1 mu-
tants (Fig. S3, A and C). To evaluate whether phospholipase A1 
activity was necessary for its function in the eye, we generated 
a transgenic construct based on the untagged genomic rescue 
construct but with mutations in the five residues critical for the 
enzymatic activity. Lipases and esterases share a short consen-
sus sequence, GXSXG. The pentapeptide is located at the active 
site of these enzymes, and the serine is part of the Ser-Asp-His 
catalytic triad of the enzyme (Derewenda, 1994). PAPLA1 con-
tains the sequence GHSLG at residues 1,682–1,686 of the pro-
tein. Site-directed mutagenesis in several lipases showed that 
the serine residue within the GXSXG sequence was the acyl-
ated center of the lipase gene family and was essential for cata-
lytic activity (Davis et al., 1990; Emmerich et al., 1992; Lowe, 
1992). Thus, to generate an enzyme lacking the lipase activity, 
we generated a PAPLA1 genomic construct without the penta-
peptide consensus sequence. We deleted residues 1,682–1,686 
(1,682–1,686-PAPLA1) in the fifth exon of the gene in this 
transgenic construct using GalK-mediated recombineering. 
This protein was expressed in S2 cells, and the immunoisolated 
protein showed only baseline activity, indicating that the active 
site mutant was catalytically inert (Fig. S3 D). Transgenic flies 
carrying this active site mutant genomic rescue construct were 
recombined into the papla1 mutant background. We then 
of this protein in the mutant. Thus, the observed defects in mo-
lecular mass are a result of lack of processing of the N-linked 
glycosylated GPCRs Rh1 and Boss by Golgi enzymes in the 
papla1 mutant.
Rh1 demonstrates aberrant localization  
in the papla1 mutant
Confocal microscopic localization of Rh1 showed that in the 
wild-type R1–R6 photoreceptor cells, much of the Rh1 local-
izes to the base of the rhabdomere, along with punctate staining 
thought to be of multivesicular bodies of endocytosed Rh1 and 
some perinuclear staining perhaps indicative of newly synthe-
sized Rh1 in the ER (Fig. S3 A, left images). However, a consid-
erable amount of Rh1 was mislocalized in the papla1 mutant 
(Fig. S3 A, middle images). Although some Rh1 was retained at 
the base of the rhabdomere, a significant fraction of the protein 
was targeted to other areas of the cell. This defect is restored in 
the rescued flies (Fig. S3 A, right images).
To determine whether transport of Rh1 was compromised 
in the papla1 mutant, we followed the synthesis and transport 
of newly synthesized Rh1 in vivo using the heat shock (hs)–Rh1-
1D4 transgene using a pulse–chase paradigm. In flies carrying 
a copy of the transgene, Rh1 can be induced in photoreceptor 
cells under the control of an hs promoter that is activated at 
37°C. The Rh1 is tagged with a sequence from the bovine opsin, 
termed Rho-1D4 at its C terminus (hs-Rh1-1D4; Colley et al., 
1995). Thus, the synthesis and fate of the hs-induced tagged 
Rh1 can be followed independent of endogenous Rh1 using a 
monoclonal antibody against Rho-1D4. The expressed Rh1-1D4 
is fully functional and rescues the Rh1-null mutant (ninaEI17) 
phenotype (Colley et al., 1995). We recombined this transgene 
into the wild-type and papla1 mutant background and followed 
the fate of newly synthesized Rh1 by Western blot analysis and 
immunofluorescence imaging. Western blot analysis showed 
that in the control flies, a pulse of 1-h hs results in the genera-
tion of a mature protein that is clearly visible in Western blots 
by 12 h, and the Rh1 is stable at least for 24 h (Fig. 5 A). 
On the other hand, in papla1 mutants that were similarly treated, 
Rh1 was always of higher molecular mass than in controls and 
was consistently in lower amounts. To follow the subcellular lo-
calization of the newly synthesized Rh1, we performed whole-
mount retinal staining of Drosophila ommatidia. Around 12 h 
after induction, we see clear staining of the rhabdomeres in the 
wild-type control flies (Fig. 5 B). Although some Rh1 is visible 
in the rhabdomeres of the papla1 mutant at this time point, it is 
faint and is only a fraction of the Rh1 synthesized in the mu-
tant. A significant fraction of the protein is ectopically localized 
in these mutants (Fig. 5 B). In fact, 8 h after induction, Rh1 
began to accumulate in the rhabdomere of the wild-type controls 
(Fig. S4 A). In the mutant, on the other hand, we observed that 
the newly synthesized Rh1 was being targeted to other areas 
of the cell, and only a small amount was being delivered to the 
rhabdomere (Fig. S4 B). The rhabdomere staining was still vis-
ible in all the wild-type controls examined 24 h after the hs, 
whereas in the mutant, many of the eyes examined exhibited 
little signal in the rhabdomere at this time (Fig. S4, C and D). 
Because by 8 h most of the Rh1 is localized to the rhabdomere 
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Figure 5. Rh1 is mislocalized in papla1 mutants. (A) In hs-Rh1-1D4 transgenic flies, Rh1 synthesis can be initiated by a pulse of hs at 37°C, and only 
the induced Rh1 can be detected by using a 1D4-specific monoclonal antibody. The pink and purple arrowheads highlight the immature forms of Rh1. 
C, control; M, mutant. (B) Immunofluorescence imaging performed on 12-h control and mutant flies with hs-Rh1-1D4. The areas enclosed by the white circles 
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of spermatogenesis. Electron microscopic examination of tes-
tis showed that early stages of spermatogenesis, including the 
generation of the 64-cell spermatid bundle, seemed to occur in 
the mutant (Fig. 6 F). We see the clear formation of the major 
and minor mitochondrial derivatives and the formation of the 
axonemal structures in the bundles. However, closer examina-
tion of the spermatid bundles showed that the mitochondrial de-
rivative and the process of individualization of the spermatids 
into sperms were defective in the mutants (Fig. 6 G). In many, 
the mitochondrial derivatives are not individualized and remain 
bridged between two spermatids. These defects lead to degen-
eration of the spermatids in the distal end of the testis. It is in-
teresting to note that although the wild-type genomic construct 
rescues all of the phenotypes observed in the papla1 mutant, the 
transgenic lines encoding the active site mutant do not rescue 
the male sterile phenotype observed in papla1 mutants while re-
storing the maturation defect of Rh1, indicating that enzymatic 
activity is important for male fertility.
Discussion
In this study, we have shown that PAPLA1, a cytosolic protein, 
is involved in the maturation of Rh1, an N-glycosylated GPCR, 
along the secretory pathway and is responsible for the transit 
of the ER-synthesized protein to the Golgi complex. GPCRs 
constitute the largest family of cell surface receptors and trans-
duce a wide range of external stimuli in cells. The glycosylation 
of GPCRs has been demonstrated to be important for normal 
folding, trafficking, cell surface expression, stability, protein–
protein interaction, and interaction with ligands in different 
GPCRs (Rademacher et al., 1988; Wheatley and Hawtin, 1999). 
In papal1 mutants, the lack of processing of the protein by com-
ponents of the Golgi complex is accompanied by two notable 
features (in addition to changes in glycosylation). First, the 
protein is mislocalized in the mutant cells (mostly in the ER), 
where normally we do not see the protein. Second, it probably 
affects the fate of the protein because we see a steady decline in 
the steady-state levels of the protein that tends to gets worse in 
older flies. It is interesting to compare the fate of Rh1 in papla1 
(this study) and dmppe mutants (Cao et al., 2011). In dmppe 
mutants, Rh1 exhibits glycosylation similar to papla1 mutants, 
at least at the level of SDS-PAGE mobility, yet Rh1 levels and 
rhabdomere targeting are not compromised. In both mutants, 
Rh1 is not deglycosylated by the Golgi -Man-II. In the case 
of papla1, Rh1 fails to reach the Golgi complex, whereas in the 
dmppe mutant, it traverses through the complex but does not 
undergo -Man-II–mediated deglycosylation. Thus, transit 
through the Golgi complex affords a great deal of stability 
performed Western blot analysis of head extracts from these flies 
for Rh1 and compared them with papla1 mutants and wild-type 
controls (Fig. S3 E). Unlike the mutant papla1 alleles, the active 
site mutant fly-produced Rh1 protein is of similar molecular 
mass as the wild-type controls. Thus, the PAPLA1 protein lacking 
the critical active site residues was able to assist in the transport 
of Rh1 from the ER to the Golgi complex for proper maturation 
of the Rh1 protein in the flies. These experiments indicate that 
enzymatic activity was not crucial for the transport function of 
the PAPLA1 protein. Most likely, the protein–protein interaction 
of PAPLA1 with COPII components will likely play an impor-
tant role in trafficking of selective proteins.
papla1 mutants display multiple phenotypes
Because papla1 mutants have a defective transport of several N-
linked GPCRs, the consequences of lower steady-state levels of 
these proteins should compromise the viability of the mutant ani-
mals. Electroretinogram (ERG) recordings of 10-d-old papla1 
mutants show decreased sensitivity of the photoreceptor cells to 
light signal (Fig. 6 A). The amplitude of response of the mutant 
is less than half of the control flies at all light intensities tested 
by ERG. Although ERGs are never fully quantitative, this obser-
vation is in line with the low levels of Rh1 found in the mutant 
flies. papla1 mutants are sensitive to starvation compared with 
the wild-type controls. The susceptibility of the mutants to star-
vation is very significant by day 10 and gets worse until about 
day 30 from when the difference remains the same (Fig. 6 B). 
Flies display an innate ability to climb up the walls of the vials 
they are housed in against the gravitational force (negative geo-
taxis). They harbor considerable segregating genetic variation 
for geotaxis behavior, and multiple additive quantitative trait 
loci contribute to this behavior. For these reasons, a negative 
geotaxis assay has generally been used to measure the vigor and 
vitality of flies. Because we propose that several GPCRs were 
compromised in the papla1 mutant, we expected the flies to do 
poorly in this test. Indeed, 30-d-old flies fared poorly compared 
with age-matched controls, indicative of decreased vitality of 
the mutant flies (Fig. 6 C). The papla1 mutant flies also have a 
20% decreased life span (unpublished data).
The papla1 mutants are male sterile. The testes of males 
are small compared with heterozygous and wild-type controls 
(Fig. 6 D). Fluorescence staining with DAPI demonstrated the 
existence of elongated spermatid bundles (Fig. 6 E, white arrows) 
along the testis in the control (Fig. 6 E, top) and the mutant 
(Fig. 6 E, bottom) flies. However, the individual needle-shaped 
nuclear staining of sperm found in the wild-type seminal vesicle 
(Fig. 6 E, top right) are absent in the mutants (Fig. 6 E, bot-
tom right), indicating a defect in the individualization process 
in the top images were enlarged threefold in the respective bottom images. (C) Rh1 colocalizes with a Golgi marker in the control w1118 cells, whereas 
we do not observe such colocalization in the papla1 mutant photoreceptor cells. (D) Rh1 was induced in rescued papla1 flies expressing V5-N-PAPLA1 
and hs-Rh1-1D4 by a 2-h hs at 37°C and fixed after 2 h. (B–D) The white arrows show colocalization of Rh1 and Golgi markers in the wild type, whereas 
yellow arrows are Rh1 staining, and the blue arrows are Golgi staining in the papla1 mutant photoreceptor cells. (E) The Rh1 protein is detectable in 
immunoprecipitates of PAPLA1 from Drosophila head microsomal preparations. Contactin and CERT were probed as negative controls. The amount of V5 
in microsomal preparation was too low to be seen on 1% of crude extracts and is not depicted. (F) V5-tagged PAPLA1 and Flag-tagged Boss were expressed 
in S2 cells. Immunoprecipitates of PAPLA1 (V5) contained Boss (Flag) but not ceramidase (CDase), a glycosylated and secreted protein. CE, crude extract; 
IP, immunoprecipitation.
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proteins to concentrate the randomly targeted Rh1 to the rhab-
domere (Tsunoda et al., 1997; Li and Montell, 2000). The Golgi 
complex has a very important role in ensuring the processing, 
sorting, and finally, targeting of newly synthesized proteins to 
the correct destination. The absence of PAPLA1 has tangible 
deleterious effects on the flies. First, in the eyes, we see a steady 
decrease in the levels of Rh1 protein which leads to a substantial 
decrease in the sensitivity of these flies to light stimuli. Another 
significant phenotype of the papal1 mutants is that they are male 
sterile. A point to note is that PAPLA1 function in spermatogen-
esis is distinct from its function in Rh1or Boss trafficking. The 
phospholipase activity of PAPLA1 is critical for spermatogen-
esis and individualization of sperms in Drosophila, whereas it is 
not required for the vesicular transport function of the protein.
and protection to Rh1. Although ectopically localized proteins 
could be unstable and degraded, the glycosylated Rh1 has been 
reported to undergo slightly faster endocytosis and degradation 
(Cao et al., 2011). This could also contribute to the low lev-
els of GPCRs observed in the papla1 mutant. N-glycan addition 
and alterations function as tags that aid in quality control of the 
protein as it folds, traffics, and matures along the secretory 
pathway. Any defect in one of these processes alters the glyco-
sylation state of the protein and subjects it to degradation or re-
processing. The failure to traverse through the Golgi complex 
does not abrogate the anterograde transport of Rh1 completely 
in the papla1 mutant because we still find that a small fraction 
of the higher glycosylated form of Rh1 localizes to the rhab-
domere. This could result from the ability of InaD and other 
Figure 6. papla1 mutants show decreased light sensitivity and increased susceptibility to starvation and are male sterile. (A) ERG analysis of control and 
papla1 mutant flies. The light was attenuated through a series of neutral density filters in which 1 = no filter, 2 = 10% transmitted light, 3 = 1% transmitted 
light, and 4 = 0.1% transmitted light. A total of six control and mutant flies were examined. (B) papla1 mutant flies succumb to starvation faster than con-
trols. The mean time for 50% survival during starvation was plotted for each age group of the control and mutant flies (n = 6). (C) papla1 mutant flies display 
decreased locomotor activity (n = 7). (D–G) papla1 mutant flies are male sterile as a result of defective spermatogenesis. (D) The papla1 mutants have 
smaller testis compared with the controls. (E) DAPI of the male sex organs. Arrows, elongated spermatid bundles. (F and G) Electron micrograph of early 
spermatid bundles (F) and mature spermatid bundles before individualization of the sperms (G). The error bars indicate standard error of the means.
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P[acman]-V5-N-PAPLA1. This construct integrates 42 bp of the V5 epi-
tope exactly before the PAPLA1 start codon and was engineered using 
galK-based positive–negative selection (Warming et al., 2005; Venken 
et al., 2006). We designed galK primers (P15 and P16) with a 75-bp ho-
mology to an area flanking the desired site. The 3 end of these primers 
binds to the galK cassette. The purified PCR products were transformed into 
SW102 cells containing the construct P[acman]-PAPLA1. The correct re-
combinants grow on M63 minimal media plates with galactose as the car-
bon source, and thus, the galK-positive colonies can be selected. Single 
red colonies were picked, and PCR (P17 and P18) was performed to con-
firm the integration of the galK cassette at the desired site. The predicted 
PCR product size was 420 bp. Primers P19 and P20 were used to gener-
ate a targeting construct containing the V5 epitope and 80 bp of homol-
ogy to replace the galK cassette. The PCR product was introduced into the 
confirmed galK-positive SW102 cells, and the targeting sequence replaced 
the galK cassette by homologous recombination. The correct recombinant 
grew on M63 plates containing biotin and 2-deoxy-galactose and ampicil-
lin with glycerol as a carbon source, and thus, we selected galK-negative 
colonies. The correct colonies were confirmed by PCR using primers P21 
and P22, and the predicted PCR product size is 311 bp. Finally, the V5 
epitope sequence and site were confirmed by sequencing.
1,682–1,686-PAPLA1. This construct deletes 15 bp of internal sequence 
coding for amino acids 1,682–1,686 in the 31-kb P[acman]-PAPLA1. We 
designed galK primers (P23 and P24) with 76-bp homology to the area 
flanking the desired site. The 3 end of these primers binds to the galK cas-
sette. Subsequent manipulations were similar to the procedure described in 
the preceding paragraph. Single red colonies were picked to perform PCR 
(P25 and P26) and confirm the integration of galK cassette at the desired 
site. Primers P27 and P28 were used to generate a targeting vector contain-
ing 106 bp of homology to replace the galK cassette. The correct recom-
binant grew on M63 plates containing biotin and 2-deoxy-galactose and 
ampicillin with glycerol as a carbon source, and thus, we selected galK-
negative colonies. The correct colonies were confirmed by sequencing.
The UAS-PAPLA1 was cloned by using LD21067 (1622894; Dro-
sophila Genomic Resource Center) as a template to PCR of the full-length 
cDNA cloned into the EcoR1–Kpn1 site of the pUAST vector. Glass multi-
mer reporter–Gal4 was used as a driver for overexpression of the protein 
in the photoreceptor cells.
For UAS-NinaA cloning, the NinaA gene was obtained by reverse 
transcribing the gene from total RNA prepared from wild-type control fly 
heads and cloned into the EcoR1–Not1 site of the pUAST vector. Transgenic 
flies were generated from a clone that was confirmed by sequencing.
Dissection and staining of testis
100 µl of cold PBS was pipetted onto the microscope slide (VWR Interna-
tional). A male adult fly is placed onto the slide, and the bottom of the fly 
body was dissected out with the forceps under a microscope. The gut was 
removed, and the whole testes together with seminal vesicles and acces-
sory glands were set aside. The testis was washed with PBS containing 
0.1% Triton X-100 three times in an Eppendorf tube. The testis was fixed 
with 4% formaldehyde solution for 30 min at room temperature. The 
testis was mounted on microscope slides with mounting medium contain-
ing DAPI, and images were captured under a confocal microscope (LSM 
510; Carl Zeiss).
Electron microscopy
For all electron microscopic experiments, unless otherwise specified, 7-d-old 
flies grown at 25°C were decapitated under anesthesia, and their heads 
were dissected and fixed in a solution sodium cacodylate buffer containing 
2% glutaraldehyde and 4% formaldehyde. They were then postfixed in 1% 
osmium tetroxide, dehydrated, and embedded in epoxy resin (Embed 812), 
and thin sections were cut (Acharya et al., 2003).
Immunohistochemistry
PAPLA1 staining was performed on papla1-null flies rescued by the V5- 
N-PAPLA1 genomic construct. In brief, tissues were dissected from adult 
flies and third instar wandering larvae, fixed with 4% paraformaldehyde, 
and blocked in PBS containing 0.2% Triton X-100 and 5% normal goat 
serum for 2 h. The tissues were stained with primary antibody in blocking 
buffer overnight at 4°C, washed with PBS, and stained with secondary anti-
body in blocking buffer at room temperature. Tissues were washed, and 
coverslips were mounted using Vectashield. The Drosophila whole-mount 
retinal staining from adult flies was performed as previously described 
(Walther and Pichaud, 2006). In brief, fly heads were bisected under 
anesthesia; the heads were then dissected in 4% paraformaldehyde in PBS. 
Recently, it was reported that mutations in the human 
DDHD1 and DDHD2 proteins cause recessive hereditary spas-
tic paraplegia (Schuurs-Hoeijmakers et al., 2012; Tesson et al., 
2012; Fink, 2013; Gonzalez et al., 2013). Those studies were not 
able to identify specific defects in protein transport but rather 
indicated a deficiency in synaptic transmission. papla1 mutants 
do not show a catastrophic decrease in the levels of the proteins 
(e.g., Rh1 or Boss) that are compromised in its absence. Rather, 
the steady decline in Rh1 in the papla1 mutant leads to a slow 
deterioration in photoreceptor function. Likewise, we see a slow 
deterioration in the vitality of the flies with regard to mobility 
and starvation responses. A similar loss of critical proteins could 
explain the onset and progress of hereditary spastic paraplegic 
in patients with mutations in DDHD1 and DDHD2 proteins.
Materials and methods
Fly stocks and husbandry
Drosophila stocks (dmppe [13884]; w1118 [3605]; and cn, bw [264]) were 
obtained from the Bloomington Stock Center. hs-Rh1-1D4 (a transgenic fly 
in which Rh1 cDNA is translationally fused to a 12–amino acid 1D4 epit-
ope at the C terminus and is driven by an Hsp70 promoter), ninaA269, and 
ninaA1 were obtained from C. Zuker (Columbia University, New York, 
NY). Drosophila were raised on standard maize meal agar and main-
tained at 25°C unless otherwise mentioned. UAS-PAPLA1 flies were gener-
ated using standard molecular biology techniques. The 31-kb genomic 
rescue construct was cloned into the P[acman] ampicillin vector using re-
combineering methods as described previously (Venken et al., 2006). The 
V5N-PAPLA1 and the active site mutant genomic constructs were generated 
using recombineering-based galK selection and counter selection using the 
31-kb genomic rescue construct (Warming et al., 2005).
Genetic screen to isolate papla1-null mutants
The PAPLA1 knockout line (papla1) was generated by ends-out homolo-
gous recombination (Gong and Golic, 2003). The targeting vector was 
designed to delete exons 2–6. Using this strategy, 5,756 bp of 18,761–
24,516 of the PAPLA1 gene was deleted. pW25 (Drosophila Genomics 
Resource Center) was used to make donor constructs. Primers P1 and P2 
were used to amplify the upstream homology arm for papla1. P3 and P4 
were used for the downstream arm. The transgenic flies carrying the donor 
constructs were crossed to flies expressing Flippase and I-SceI and then 
used. G1 female progeny were crossed to males expressing Flippase con-
stitutively, and 1,000 lines were generated. In G2 generation, flies were 
screened for red-eyed progeny. These flies with potential targeted mutants 
were crossed to appropriate flies to establish stocks. The targeted alleles 
were confirmed by PCR-based techniques. The mutant flies have red eyes 
with the white+ gene. The white+ was removed by crossing to Cre recombi-
nase–expressing flies. Finally, the white-eyed mutants were confirmed by 
PCR using primers P5 and P6. The predicted length of PCR products is 362 
bp in papla1 and 6,442 bp in w1118 (see Table 1 for primer sequences).
Generation of rescue constructs by homologous recombination
To generate transgenic flies expressing the PAPLA1 protein at the endoge-
nous level, three P[acman]-based constructs were generated using recom-
bineering and recombineering-based galK selection (Warming et al., 
2005; Venken et al., 2006): (1) P[acman]-PAPLA1, by direct retrieval of 
PAPLA1 genomic DNA plus the promoter region from bacterial artificial 
chromosome (BAC) into the P[acman] vector; (2) P[acman]-V5-N-PAPLA1, 
P[acman]-PAPLA1 with a V5 tag at the N termini; and (3) 1,682–1,686-
PAPLA1, the active site mutant.
P[acman]-PAPLA1. The left homology arm (primers P7 and P8) and 
right homology arm (primers P9 and P10) were first inserted into the 
multiple cloning site of P[acman] (1245; Drosophila Genomics Resource 
Center). The constructs were linearized with BamHI and transformed into 
recombineering bacteria DY380 containing PAPLA1 BAC. We retrieved 
30,484 bp of DNA from BAC into the P[acman] constructs by homologous 
recombination. The final constructs were confirmed by PCR. Primers P11 
and P12 were used for amplifying upstream junctions, and P13 and P14 
were used for downstream junctions.
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Andor Technology) with an 8-µm pixel size. Images were acquired with a 
Plan Apochromat 100×, 1.40 NA oil immersion objective, and the image 
pixel size of the raw data was 50 nm. Images were acquired with five or 
three grid rotations. Raw images were reconstructed and processed using 
the Zen 2011 software (Carl Zeiss) with a structured illumination micro-
scope analysis module to generate the final images. The channel alignment 
reference image was based on a multicolor bead slide (TetraSpeck; Life 
Technologies). The colors were aligned to the channel using an affine fit 
that corrected for axial shift, lateral shift, rotation, and spine. Colors were 
aligned to one structured illumination microscope pixel accuracy (25 nm). 
The images obtained were then processed in Photoshop for cropping, 
arrangement, and presentation.
Western analysis
Fly heads were dissected from 3-d-old flies (unless otherwise specified), ho-
mogenized in sample buffer, boiled, and subjected to SDS-PAGE and 
Western analysis. For detection of Rh1 and other proteins detected in the 
same blot, the samples were incubated at 37°C for 40 min and then sub-
jected to SDS-PAGE and Western blotting. Antibodies to Rh1 (rabbit poly-
clonal), NinaA (rabbit), and Trp (rabbit) were gifts from C. Zuker, antibody 
to NinaC (rabbit) was a gift from C. Montell (Johns Hopkins University, Bal-
timore, MD), and the rhodopsin (4C5), neuroglian, and the tubulin (E7) 
mouse monoclonal antibodies were obtained from the Developmental Stud-
ies Hybridoma Bank. The guinea pig anticontactin antibody was a gift 
from M. Bhat (The University of Texas, Austin, TX). The Boss monoclonal 
antibody was a gift from L. Zipursky (University of California, Los Angeles, 
Los Angeles, CA).
The tissues surrounding each compound eye were removed using forceps, 
and the lens material surrounding each eye was carefully removed from the 
eye. The dissected eyes were pooled and processed for antibody staining. 
The antibody to Lava lamp (rabbit) was a gift from J. Sisson (University of 
Texas, Austin, TX) and C. Fields (Harvard Medical School, Boston, MA). 
The rabbit antibody to NinaC was a gift from N. Colley (University of Wis-
consin, Madison, WI). Anti-V5 mouse monoclonal (1:200; Invitrogen) and 
polyclonal (rabbit) antibodies (1:200; Sigma-Aldrich) were used in immuno-
localization experiments. The anti-Golgi mouse monoclonal antibody 
(7H6D7C2; 1:200) was obtained from EMD Millipore. The rhodopsin 
mouse monoclonal antibody (4C5) was obtained from Developmental 
Studies Hybridoma Bank. The RHO-1D4 mouse monoclonal antibody 
(1:25) was obtained from The University of British Columbia (Vancouver, 
British Columbia, Canada). Alexa Fluor dye–conjugated (488 nm, 564 
nm, and 647 nm) secondary antibodies were used for immunolocalization 
in fluorescence experiments. DAPI was used for staining the nuclei. Retinal 
immunolocalization data were acquired on a confocal microscope (LSM 
510) using a 60× objective. For quantification of colocalization of Sec23 
and PAPLA1, six areas from three confocal sections of the accessory glands 
with larger immunostained structures were examined. Individual green, 
blue, and overlapping structures were counted, and the percentage of 
overlap was calculated for each of the areas. The images were processed 
in Photoshop (Adobe) for arrangement, cropping, and presentation.
SR-SIM
The images were acquired on a demonstration model of ELYRA S1 SR-SIM 
and an electron-multiplying charge-coupled device camera (iXon EM 885; 
Table 1. Primer sequences used in this study
Primers Sequences (5 → 3)
P1 TCATCGTACGCATCAAACGGGCATCGAATTTGG
P2 GCTCGGCGCGCCTGATGCCTAATTGTTTATAGTTGGAGAT
P3 TATATAGGTACCGAGGATCAGGACGAGAGTTC
P4 TATATAGCGGCCGCCCAGTCACCACAACAAC
P5 TGCGGCTATCGCTTGTTTAG
P6 GTTTGCAAGATGAACTGGCA
P7 AATTGGCGCGCCTTAAACGCAGTCATGTGCTGCC
P8 ATATGGATCCCGTACGCGCAGGCACGGAAAAGCGTC
P9 ACGAGAGCTCTGTTGGATCCAACG
P10 CGCGTTAATTAACGAAGCGCTTCCCAAATAATACCTC
P11 TTTAAACCTCGAGCGGTCCGTTATC
P12 GCTCGCACACCGTGTATTTTCAG
P13 AATCAGCACAGACAGCCAGGTG
P14 CTAAAGGGAACAAAAGCTGGGTAC
P15 GCAACTGTGCACTTGGCACACATCTTCATATCGAGTTAGCCCAATTTAAAGCTCCAGATCGGCCGCTAATATGCCTGTTGACAATTAATCATCGG
CATAG
P16 AAGCGGATTTTTAACGACACGCGTCTGGTTTGCGTTGTTGTTTACGCGAGCGGACACGTCACCTTTCGATCTTTCCGACTCAGCACTGTCCTGCT
CCTTG
P17 CGGCTGTATCGTCGCGCTGATC
P18 GCAGCCGAGCAACAGGTGACC
P19 CTAAGGCAACTGTGCACTTGGCACACATCTTCATATCGAGTTAGCCCAATTTAAAGCTCCAGATCGGCCGCTAATATGGGTAAGCCTATCCCTAAC
CCTCTCCTCGGTCTCGATTCTACG
P20 AAGCGGATTTTTAACGACACGCGTCTGGTTTGCGTTGTTGTTTACGCGAGCGGACACGTCACCTTTCGATCTTTCCGACGTAGAATCGAGACCGAG
GAGAGGGTTAGGGATAGGCTTACC
P21 CCTATCCCTAACCCTCTCCTCG
P22 GCAGCCGAGCAACAGGTGACC
P23 GGCAGATGCGCTTAACGATGTCTACCTGAAGTACCGAATGCGGCACCCTGAATTCAATGGGGGAGTTTCGCTGGCACCTGTTGACAATTAATCAT
CGGCA
P24 AAGTTTTACTCACTTTATTCTCTTCCTCGCTTTCCTTGAGCGGTTCCTGATGGCACAATAAATCGAATAGGATTAGGGATCAGCACTGTCCTGCT
CCTT
P25 GCATCGACGAAAAGCTGAAATCC
P26 TTTCAGACTCATGATCTGCCTCC
P27 GAAATACTGTCAAAAGATCATGAACACGGTGGCAGATGCGCTTAACGATGTCTACCTGAAGTACCGAATGCGGCACCCTGAATTCAATGGGGGAG
TTTCGCTGGCA
P28 AATGGTTTTATTAATCGCTAAAGTTTTACTCACTTTATTCTCTTCCTCGCTTTCCTTGAGCGGTTCCTGATGGCACAATAAATCGAATAGGATTAG
GGATGCCAGCGAAACTCCCCCATTGAATT
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denature and loaded on 8 or 10% SDS-PAGE. Proteins were transferred to 
a polyvinylidene fluoride membrane, and standard Western blotting was 
performed using a rabbit COPII antibody (Thermo Fisher Scientific).
Cell culture
Drosophila S2 cells and stable S2 cells were grown at 25°C in Schneider’s 
Drosophila medium (Invitrogen) supplemented with l-glutamine, 10% FBS, 
and penicillin-streptomycin. Stable S2 cells expressing a V5-tagged PAPLA1 
under blasticidin (A.G. Scientific, Inc.) selection and Flag-tagged Sec23 or 
Sec31 under hygromycin (Roche) selection were used in the experiments.
Immunoprecipitation of PAPLA1 and interacting proteins in S2 cells
Antibodies were conjugated to Dynabeads protein G (Invitrogen) by add-
ing 4 µg of mouse IgG, anti-V5, or anti-Flag antibodies diluted in 400 µl 
PBS with 0.02% Tween 20 to 30 µl Dynabeads protein G and rotated for 
2 h at 4°C. Beads were washed in PBS with 0.02% Tween 20. Cells were 
plated at 106 in a 10-cm dish. Cells were induced with CuSO4 at a final 
concentration of 500 µM CuSO4. After 24 h, cells were harvested, washed 
with cold PBS, suspended with cold 1.5 ml lysis buffer (PBS, 5 mM EDTA, 
and 0.6% NP-40) containing protein inhibitors, and rotated for 2 h at 4°C. 
The lysate was centrifuged at 10,000 g for 10 min to remove the cell de-
bris. 500 µl supernatant was added to each conjugated Dynabeads pro-
tein G and rotated for 3 h at 4°C. The beads were washed five times with 
lysis buffer, and the samples were eluted in 50 µl SDS sample buffer. The 
sample was loaded on SDS-PAGE gels, and Western blotting was performed 
with appropriate antibodies. For Boss immunoprecipitation, V5 epitope–
tagged PAPLA1 (pMT/V5; Invitrogen) protein and Flag-tagged Boss protein 
under an actin promoter (modified pAc5.1; Invitrogen) were transfected into 
S2 cells. 24 h after transfection, PAPLA1 was induced with copper sulfate, 
and immunoprecipitation and Western blot analysis were performed as de-
scribed earlier in this paragraph. For Boss, ceramidase, a glycosylated and 
secreted protein, was used as a negative control (Acharya et al., 2008).
Immunoprecipitation of PAPLA1 and the deletion mutant for 
phospholipase A1 assay
The C-terminally V5 epitope–tagged wild-type PAPAL1 and active site mu-
tant PAPLA1 were stably expressed in S2 cells under blasticidin selection. 
Induction of protein expression and immunoprecipitation was performed 
as described for PAPLA1 and COPII coimmunoprecipitation, except protein 
G–Sepharose beads were used for immuno–pull-down. Protein G beads 
containing equal amounts of wild-type and mutant proteins were used for 
the assay.
Electroretinography
ERGs were recorded as described previously (Gavin et al., 2007). In brief, 
flies were anesthetized with carbon dioxide and immobilized on a rotating 
disc using molten myristic acid (Akronchem). The voltage changes were re-
corded with a SignaGel (Parker Laboratories, Inc.)-filled electrode that was 
placed in contact with the surface of the eye, whereas a second similarly 
gel-filled electrode was impaled into the thorax. A halogen lamp controlled 
by a shutter (model T132; Uniblitz) was used to generate light signals. All 
light treatments, unless otherwise stated, were performed using a 580-nm 
filter. The light was attenuated through neutral density filters (Oriel Instru-
ments). An amplifier (DAM50; World Precision Instruments) was used to 
amplify the voltage changes recorded using PowerLab 4/30 (ADInstru-
ments) and analyzed with the help of Chart 5 software (ADInstruments).
Negative geotaxis experiments
The negative geotaxis assay was performed as described previously with 
some changes (Rao et al., 2007). 30-d-old flies maintained on a normal 
diet were taken in an empty vial (10-cm vials with 15 flies in each). The 
vials were tapped twice on the table to initiate the flies, and the number of 
flies that crossed a reference mark (7 cm from the bottom of the vial) in 30 s 
was counted. The procedure was repeated for seven trials, and between 
trials, the flies were allowed to rest for 30 s.
Glycan analysis
In-gel tryptic digestions of Rh1 immunoprecipitated from wild-type and 
papla1 mutant heads were based on previously published procedures 
(Küster et al., 1997; Chill et al., 2009). In brief, silver-stained SDS gel 
pieces were cut into small pieces and washed in a solution containing 40 mM 
ammonium bicarbonate (AmBic) for 10 min and were then dehydrated 
with 100% acetonitrile for 10 min. This procedure was repeated until 
the gel turned white. Subsequently, the dehydrated gel pieces were reswol-
len for an hour at 55°C in a solution containing 10 mM DTT and 40 mM 
AmBic. After cooling to room temperature, this solution was replaced with 
PNGase F treatment of Rh1 or Boss
15 w1118 and 15 papla1 mutant heads were collected and homogenized 
initially in 100 µl PBS, and then, the volume was adjusted to 1 ml, mixed 
well, and centrifuged at 1,000 g to remove debris. The supernatant was 
centrifuged at 20,000 g to pellet membranes. The membrane pellet was 
resuspended in 90 µl H2O, and 10 µl of 10× denaturing buffer (5% SDS 
and 400 mM DTT) was added, mixed by pipetting, and allowed to solu-
bilize at 4°C for 30 min. The supernatant was centrifuged at 10,000 g to 
remove insoluble proteins. To 10 µl supernatant, 2 µl of 10% NP-40 and 
2 µl of 10× reaction buffer (500 mM sodium phosphate, pH 7.5) were 
added, and the volume was adjusted to 19 µl and mixed gently. Finally 
1 µl PNGase F (500,000 U/ml) was added, mixed, and incubated at 
37°C for 1 h. The reaction was terminated by adding 2× SDS loading 
dye, and the products were run on a 13% SDS-PAGE gel for Rh1 and a 
10% SDS-PAGE gel for Boss (for the latter, the gels were overrun to resolve 
better). Subsequently, proteins were transferred to polyvinylidene fluor-
ide membrane, and Western blotting was performed with mouse Rh1 or 
Boss antibodies.
Immunoprecipitation of Rh1
100 w1118 and papla1 heads were homogenized initially with 200 µl PBS, 
and the volume was adjusted to 1.5 ml and mixed well. The lysates were 
centrifuged at 1,000 g to remove debris. Supernatant was centrifuged at 
20,000 g for 1 h, and membrane pellet was resuspended in solubilization 
buffer (50 mM Tris-HCl, pH 7.4, 300 mM NaCl, 5 mM EDTA, and 1% 
n-dodecyl maltoside). The membrane was allowed to solubilize at 4°C for 
3–4 h on a rocker followed by centrifugation at 10,000 g for 10 min to 
remove detergent-insoluble proteins. To the supernatant, 5 µl Rh1 antibody 
(ascites of 5–10 µg) was added and mixed, and 50 µl protein G beads 
was added and left on a rocker overnight at 4°C. Beads were collected 
by centrifugation (1,000 g) and washed three times with solubilization buf-
fer, two times with PBST (PBS with Tween), and finally, two times with PBS 
(3–5 min each). After PBS wash, the entire buffer was removed by pipet-
ting, and 20 µl elution buffer was added, gently mixed, and incubated on 
ice for 5 min. The eluate was collected by pipetting and mixed with 10 µl 
SDS loading dye. The sample was analyzed on 13% SDS-PAGE (gel was 
overrun until a 29-kD marker band reached near the end of the gel) and 
silver stained.
Coimmunoprecipitation of hs-Rh1-1D4 and V5N-PAPLA1 flies
Transgenic hs-Rh1-1D4; V5N-PAPLA1 flies (eclosed in <24 h) were incu-
bated for 1 h at 37°C and recovered for 3 h at 25°C. Heads were de-
capitated (600) and homogenized in 3 ml of buffer A (20 mM Tris-HCl, 
pH 7.5, 50 mM NaCl, 2.5 mM EDTA, and protease inhibitors). The ho-
mogenate was centrifuged at 10,000 g for 10 min to remove debris and 
rhabdomeral membranes. The supernatant was centrifuged at 200,000 g 
for 1 h with a rotor (MLS 130K; Beckman Coulter), and the microsome pel-
let was resuspended in 1 ml of buffer B (20 mM Tris-HCl, pH 7.5, 50 mM 
NaCl, 2.5 mM EDTA, 0.1% sodium dodecyl maltoside, and protease in-
hibitors) and incubated at 4°C for 2 h. The insoluble proteins and mem-
branes were removed by centrifugation at 10,000 g for 10 min. The 
supernatant was incubated with 30 µl protein G beads coupled to IgG- or 
V5 epitope–specific antibodies (4 µg) for 3 h at 4°C. Beads were collected 
by centrifugation at 100 g for 3 min and washed three to five times with 
buffer B, and proteins were eluted by SDS loading buffer. The samples 
were analyzed by Western blotting with appropriate antibodies. The blots 
were probed for contactin, a glycosylated glycosylphosphatidylinositol- 
anchored membrane protein apparently unaffected in the papla1 mutant, 
and CERT (ceramide transfer protein), which localizes to the ER and Golgi 
complex, and both served as negative controls (Faivre-Sarrailh et al., 
2004; Rao et al., 2007).
Immunoprecipitation of PAPLA1 and Western blots with Sec23
About 100 V5N-PAPLA1 transgenic fly heads (<1 d old) were homog-
enized in 1 ml PBS containing 0.4% NP-40 and 2.5 mM EDTA (solu-
bilization) and allowed to solubilize for 2–4 h at 4°C on a rocker. The 
lysates were centrifuged at 10,000 g to remove the insoluble fraction. To 
the supernatant, 20 µl protein G beads was added and incubated on a 
rocker at 4°C for 1 h. The beads were removed by centrifugation, and 
the supernatant was collected in a fresh tube. To the supernatant, 4 µg of 
mouse V5 antibody (Invitrogen) conjugated to 20 µl protein G beads was 
added and incubated at 4°C for 3 h on a rocker. Beads were collected by 
centrifugation and washed three times with solubilization buffer (10 min 
each). Finally, the entire buffer was removed from the beads, and 2× SDS 
loading dye was added to elute proteins. Eluted proteins were boiled to 
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a solution containing 55 mM iodoacetamide and incubated in the dark for 
45 min. Subsequently, the gel pieces were washed with 40 mM AmBic and 
dehydrated (10 min) in acetonitrile. The gel pieces were rehydrated on ice 
in digestion solution (containing 50 µg trypsin and chymotrypsin in 1 ml of 
40-mM AmBic) for 45 min and then incubated overnight at 37°C. The fol-
lowing morning, the incubation solution was collected, and gel pieces were 
serially extracted with 20, 50, and 80% acetonitrile (all in 5% aqueous 
formic acid). The original incubation solution and all subsequent extracts 
were combined, dried, and subjected to chromatography (C18 Sep-Pak; 
Waters) to separate peptides and glycopeptides (Aoki et al., 2007). 
PNGase F digestion was performed to release the glycans from the glyco-
peptides and was permethylated for nanospray ionization MS. An ion trap 
instrument (NSI-LTQ Orbitrap Discovery; Thermo Fisher Scientific) was used 
for identification as previously described (Aoki et al., 2007). After permeth-
ylation, dried glycans were dissolved in 1 mM NaOH in 50% methanol 
and directly infused into the instrument at a syringe flow rate of 0.40–0.60 
µl/min. For fragmentation by collision-induced dissociation in MS/MS and 
MSn modes, 40% collision energy was applied. The total ion mapping 
functionality of the XCalibur software package (version 2.0; Thermo Fisher 
Scientific) was used to detect and quantify the prevalence of individual 
glycans in the total glycan profile. Most permethylated oligosaccharides 
were identified as singly, doubly, and triply charged species by nanospray 
ionization–MS. Peak intensities for all charge states of a given glycan with 
mass per charge <2,000 were summed together for quantification.
Online supplemental material
Fig. S1 shows that PAPLA1 colocalizes with COPII and not Golgi compo-
nents, that it interacts with Sec23 and Sec31 in S2 cells, and that although 
Rh1 is affected in the papla1 mutant, other phototransduction components 
are not compromised. Fig. S2 shows that steady-state levels and apparent 
molecular masses of GPCRs Rh1 and Boss are compromised in papla1 mu-
tants, whereas other glycosylated proteins, such as contactin and neuro-
glian, are not affected. Fig. S3 shows that Rh1 is aberrantly localized 
in the papla1 mutant, that the N-terminal V5-tagged PAPLA1 genomic 
construct rescues transport defect in the papla1 mutant, that the active 
site mutant protein is catalytically inactive, and that the active site mu-
tant transgenic construct is able to rescue Rh1 maturation in papla1 mu-
tants. Fig. S4 shows a defect in Rh1 transport in papla1 mutants using 
a pulse–chase paradigm and immunofluorescence experiments. Fig. S5 
demonstrates that the Rh1 is mostly retained in the ER in papla1 mu-
tants. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201405020/DC1.
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